The $255 level is a calculated average drawn from seven recent individual targets rather than an official consensus figure. Those targets fall between roughly $240 and $275. Recent updates include Macquarie at $250, Guggenheim at $254, Needham at $255, Wedbush at $240, Citizens at $265, and Cantor Fitzgerald at $275 (overweight, raised). KeyBanc lifted its target to $245 from $220 while retaining an overweight rating. Most firms pointed to solid demand checks and continued confidence in ZS’s AI security and Zero Trust positioning, though some noted a higher bar for execution.
Broader aggregator numbers differ because they often mix in older targets. One common one-year target sits near $235, while others cluster around $238 or $259. The contrast between headline averages and newer upward revisions shows why a single consensus number should be viewed with care. Bullish analysts highlight the growing AI security opportunity, while more measured voices focus on decelerating growth and valuation sensitivity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares closed at $225.09 on November 3, 2026, inside a 52-week range of about $114.63 to $336.99 and a market capitalization near $36.7 billion. Reaching $255 would require a gain of roughly 13.3%, a notable move that would lift the stock above its recent October range yet still leave it below last year’s peaks.
The trajectory hinges on execution. Zscaler guided fiscal 2027 revenue to approximately $3.91 billion to $3.94 billion, pointing to growth of about 16.6% to 17.5% — respectable but slower than the 25% posted in fiscal 2026. The company has described agentic AI security as its “biggest opportunity ever,” with a long-term $8 billion ARR ambition. Turning that narrative into sustained billings and net-new ARR growth remains the central test.
The 52-week range of roughly $114.63 to $336.99 places the stock in the middle of its longer-term band. A key support zone sits near $220, close to recent closes, with further support around $207 from mid-October trading. On the upside, $238 to $240 has served as near-term resistance, a level touched on November 2 before a pullback. The $255 target sits just above that zone, so a decisive break above $240 would mark an important technical step.
Analyst price targets generally reflect a 12-month research horizon, though individual firms may vary. The next major catalyst is Zscaler’s earnings report, expected around November 24, 2026, which will test first-quarter revenue and ARR guidance against raised Street expectations. Investors should also track post-earnings analyst revisions, the integration of new sales leadership, adoption of AI security products, and any shifts in enterprise spending or interest-rate expectations that could influence valuation.
In my own work, Tickeron’s AI Daily Buy/Sell Signals have become a practical way to stay on top of market shifts. The system applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on evolving technical conditions and data-driven analysis. For someone blending fundamental research with automated signals, these outputs offer a concise way to spot changing trends and manage positions more efficiently.
Whether ZS reaches $255 ultimately rests less on the target number itself and more on whether the company can sustain credible ARR growth while stabilizing execution. The central target, derived from seven recent analyst price targets averaging about $255 with a range of $240 to $275, implies a roughly 13% advance from current levels — attainable given the company’s track record, yet far from assured. Strong AI security demand and a constructive analyst tone lend support, while decelerating growth, ongoing losses, and leadership transition remain real obstacles. The upcoming earnings report and follow-on analyst revisions will provide the clearest near-term indication of which factors prevail.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Stochastic Oscillator for ZS moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 52 similar instances where the indicator exited the overbought zone. In 42 of the 52 cases the stock moved lower. This puts the odds of a downward move at 81%.
The 10-day RSI Indicator for ZS moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 29 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Moving Average Convergence Divergence Histogram (MACD) for ZS turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 35 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
ZS broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ZS as a result. In 68 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
Following a +9.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZS advanced for three days, in 260 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 182 of 230 cases where ZS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.126) is normal, around the industry mean (16.526). ZS has a moderately low P/E Ratio (-577.154) as compared to the industry average of (57.809). Projected Growth (PEG Ratio) (2.043) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.287) among similar stocks. P/S Ratio (9.158) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ZS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an antivirus & cloud security platform
Industry ComputerCommunications